Skip to main content

BPCI Advanced Model Extension

Doctor with stethoscope, notes and calculator

CMS recently made several major announcements about the Bundled Payments for Care Improvement Advanced Model. 

  • The model, which was due to expire at the end of 2023 (Model Year 6), will be extended for an additional two years through Dec. 31, 2025. 
  • New applications will be accepted in 2023 for the two-year extension. Participants still active in Model Year 6 can continue without reapplying by signing an amended and restated participation agreement for Model Year 7. 
  • New methodological changes will be implemented for Model Year 6, which starts on Jan. 1, 2023. Methodological changes include that:
    • the CMS Discount Factor for medical clinical episodes will be reduced from 3% to 2%; 
    • the Peer Group Trend Factor Adjustment cap for all clinical episodes will be reduced from 10% to 5%;
    • the Major Joint Replacement of the Upper Extremity clinical episode category will become a multi-setting episode category by allowing episodes to be triggered when the procedure is performed in the hospital outpatient setting. All episodes under this clinical episode category will include additional adjustments to account for trauma and fractures; and
    • episodes that co-occur with a COVID-19 diagnosis will no longer be excluded from the model; however, the pricing methodology will include risk adjustment for when a beneficiary has a COVID-19 diagnosis during the episode. 

What do these changes mean for the BPCIA model?

Enrollment in the BPCIA model has declined over the last several years due to the expansion of risk to entire clinical episode service line groups and complex pricing methodology changes making financial goals more difficult to attain. These challenges have included the exit of major large conveners and their cohorts of downstream episode initiators. Under the new two-year extension, providers that previously participated in BPCIA will have the opportunity to reapply and providers who have not yet participated will have an opportunity to get involved. BPCIA has not had an open enrollment period since Model Year 3 in 2019 (calendar year 2020). 

New pricing methodology changes are a step in the right direction to retain enrollment of existing providers and encourage the application of non-participating providers. These changes will favor participants by reducing uncertainty in target prices, particularly as it concerns the Peer Group Trend Factor Adjustment. The inclusion of episodes when a beneficiary has a COVID-19 diagnosis will boost episode volume. It also includes fair additional risk adjustment to account for changes in episode expenditures due to the presence of a COVID-19 diagnosis. In addition, participants currently at risk for medical clinical episode categories will have higher target prices. 

There have been growing concerns about CMS’ ability to evaluate the effectiveness of this model since substantial changes in participation may result in selection bias. CMS will be able to better evaluate the impact of BPCIA by making these changes. 

What should providers do in the interim?

Current model participants can evaluate the impact of these changes compared to prior model years when evaluating their upcoming new baseline data and as Model Year 6 commences. 

Providers not currently enrolled in BPCIA should look for an announcement requesting applications from CMS in early 2023 for their chance to apply for the extension period. 

DataGen has the expertise to help providers evaluate opportunities under bundled payment arrangements and supports providers with their data analysis needs throughout the performance period. Contact us to learn more. 

Comments

Popular posts from this blog

Alternative payment models: Strategies for success

In this edition of DataGen Insights, we look at how alternative payment model participants can ensure their processes and workflows are optimally set up for success. To help, DataGen listed the top three strategies all providers participating in APMs can employ and created a handy checklist to enable maximum returns and reduce financial risk. Please explore our website to learn more about our  products and services .  Download DataGen Insights today .  We hope you enjoy!

Why it's critical for Primary Care First participants to control and understand leakage

Patients' primary care visits outside of their attributed primary care office, also called “leaked” patient visits, can have unintended consequences for Primary Care First participants. Beginning July 2022, PCF Cohort 1 will face a reduction in population-based payments based on their leakage rate. The payment adjustment will be based on their 2021 claims data and will roll forward quarterly. To calculate your leakage rate, divide the number of qualifying visits and services your attributed beneficiaries have made to care centers outside of your practice (for example, visits to urgent care centers) by the total number of qualifying visits and services your attributed beneficiaries have made. Calculating primary care leakage with claims data alone comes with some unintended challenges. Unfortunately, some circumstances can unfairly and negatively impact a practice’s leakage rate: Nuances classifying care delivered by provider team members: It’s difficult to distinguish

Start the year off right: DataGen answers your Primary Care First questions

The Primary Care First Model , an alternative payment model offering an innovative payment structure for the delivery of advanced primary care, welcomed the involvement of Cohort 2 participants on Jan. 1 . This cohort, which was open to all primary care practices that met the eligibility criteria, will participate from 2022 to 2026. Participants in PCF Cohorts 1 and 2 can expect the following benefits: an opportunity to increase revenue with performance-based payments that reward participants for reducing acute hospital utilization; the ability to assess and improve performance through actionable, timely data; less administrative burden so providers can spend more time focusing on patient needs; and potential to become a Qualifying APM Participant , which includes eligibility for a 5% incentive payment and eliminates Merit-based Incentive Payment System reporting requirements. To ensure that new and prior participants succeed in this model, DataGen has compiled and answered some of t